4-(8-Methoxy-1-((R)-1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinoline-7-yl)-3,5-dimethylisoxazole

ID: ALA4878439

Cas Number: 1422554-34-4

PubChem CID: 71258968

Product Number: I647703, Order Now?

Max Phase: Preclinical

Molecular Formula: C25H30N4O4

Molecular Weight: 450.54

Molecule Type: Unknown

Associated Items:

This product is currently unavailable

Names and Identifiers

Canonical SMILES:  COC[C@@H](C)n1c(C2CCOCC2)nc2cnc3cc(-c4c(C)noc4C)c(OC)cc3c21

Standard InChI:  InChI=1S/C25H30N4O4/c1-14(13-30-4)29-24-18-11-22(31-5)19(23-15(2)28-33-16(23)3)10-20(18)26-12-21(24)27-25(29)17-6-8-32-9-7-17/h10-12,14,17H,6-9,13H2,1-5H3/t14-/m1/s1

Standard InChI Key:  HYPXHDJBILNWLI-CQSZACIVSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    8.4232  -18.9285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4221  -19.7558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1368  -20.1687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1351  -18.5157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8505  -18.9248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8512  -19.7516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5665  -20.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2815  -19.7478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5609  -18.5106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2734  -18.9189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8818  -18.3674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5454  -17.6182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7290  -17.7069    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1749  -17.0957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7087  -18.5161    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7085  -17.6911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7074  -20.1677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9567  -19.8349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4042  -20.4475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8162  -21.1623    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6232  -20.9913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7849  -19.0280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2369  -21.5427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9554  -16.9024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7781  -16.8988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1880  -16.1871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7767  -15.4717    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9507  -15.4725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5362  -16.1887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4272  -16.3102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8731  -15.6990    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1255  -14.9135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3685  -17.2699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8 10  1  0
  9  5  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  1  0
 13 14  1  0
  1 15  1  0
 15 16  1  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 17  2  0
 18 22  1  0
 21 23  1  0
 12 24  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 14 30  1  0
 30 31  1  0
 31 32  1  0
 14 33  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4878439

    I-BET282

Associated Targets(Human)

CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CREBBP Tchem CREB-binding protein (1602 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 450.54Molecular Weight (Monoisotopic): 450.2267AlogP: 4.97#Rotatable Bonds: 6
Polar Surface Area: 84.43Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.35CX LogP: 2.74CX LogD: 2.74
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.41Np Likeness Score: -0.88

References

1. Jones KL, Beaumont DM, Bernard SG, Bit RA, Campbell SP, Chung CW, Cutler L, Demont EH, Dennis K, Gordon L, Gray JR, Haase MV, Lewis AJ, McCleary S, Mitchell DJ, Moore SM, Parr N, Robb OJ, Smithers N, Soden PE, Suckling CJ, Taylor S, Walker AL, Watson RJ, Prinjha RK..  (2021)  Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression.,  64  (16.0): [PMID:34387088] [10.1021/acs.jmedchem.1c00855]
2. Humphreys PG, Anderson NA, Bamborough P, Baxter A, Chung CW, Cookson R, Craggs PD, Dalton T, Fournier JCL, Gordon LJ, Gray HF, Gray MW, Gregory R, Hirst DJ, Jamieson C, Jones KL, Kessedjian H, Lugo D, McGonagle G, Patel VK, Patten C, Poole DL, Prinjha RK, Ramirez-Molina C, Rioja I, Seal G, Stafford KAJ, Shah RR, Tape D, Theodoulou NH, Tomlinson L, Ukuser S, Wall ID, Wellaway N, White G..  (2022)  Identification and Optimization of a Ligand-Efficient Benzoazepinone Bromodomain and Extra Terminal (BET) Family Acetyl-Lysine Mimetic into the Oral Candidate Quality Molecule I-BET432.,  65  (22.0): [PMID:36378954] [10.1021/acs.jmedchem.2c01102]

Source